Teva Pharmaceuticals USA recalls ADRUCIL (fluorouracil injection, USP), 5 g/100 mL (50 mg/mL) glass vials, 5 x 100 ml vials per carton, manufactured by T
Recalled September 2, 2015 · FDA recall D-1351-2015 · Teva Pharmaceuticals USA
Hazard
Presence of Particulate Matter: silcone rubber and fluorouracil crystals found floating in solution · FDA Class I
Units
6001 vials
Sold at
Nationwide.
Description
Presence of Particulate Matter: silcone rubber and fluorouracil crystals found floating in solution
Product
ADRUCIL (fluorouracil injection, USP), 5 g/100 mL (50 mg/mL) glass vials, 5 x 100 ml vials per carton, manufactured by Teva Parenteral Medicines, Inc., Irvine, CA. NDC 073-3019-11 (individual vial), NDC 0703-3019-12 (carton of five).
Manufacturer(s)
Teva Pharmaceuticals USA
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →